Extracellular adenosine has been implicated as an innate antiinflammatory metabolite, particularly during conditions of limited oxygen availability such as ischemia. Because extracellular adenosine generation is primarily produced via phosphohydrolysis from its precursor molecule adenosine-monophosphate (AMP) through the enzyme ecto-5-nucleotidase (CD73), we examined the contribution of CD73-dependent adenosine production in modulation of intestinal ischemia-reperfusion (IR) injury. Following transcriptional and translational profiling of intestinal tissue that revealed a prominent induction of murine CD73, we next determined the role of CD73 in protection against intestinal IR injury. Interestingly, pharmacological inhibition or targeted gene deletion of CD73 significantly enhanced not only local intestinal injury, but also secondary organ injury, following IR as measured by intestinal and lung myeloperoxidase, aspartate and alanine aminotransferase, interleukin (IL) -1, IL-6, and histological injury. To confirm the role of CD73 in intestinal adenosine production, we measured adenosine tissue levels and found that they were increased with IR injury. In contrast, CD73-deficient (cd73 
The consequences of depriving an organ of its blood supply have long been recognized as a critical factor in the clinical outcome of stroke, hemorrhagic shock and organ transplantation. Although restoration of blood flow to an ischemic organ is essential to prevent irreversible tissue injury, reperfusion can also augment tissue injury in excess of that produced by ischemia alone by causing destruction of vascular integrity, tissue edema, and disturbances in cellular energy balance (1) . Cellular damage after reperfusion of previously viable ischemic tissue is defined as ischemia-reperfusion (IR) injury (1) .
Gastrointestinal ischemia-reperfusion generally stems from interruption of blood flow within the superior mesenteric artery or vein and leads to small intestine hypoperfusion (2) . Intestinal IR is encountered in a variety of clinical conditions such as hemorrhagic shock, strangulation-obstruction of the intestine, sepsis, vascular surgery, small bowel transplantation, cardiopulmonary bypass, and abdominal aortic surgery, and it can result in multiple organ failure (3) . IR of the intestine is a systemic phenomenon that may result in bacterial translocation, endotoxemia, acute respiratory distress syndrome (ARDS) and acute hepatic injury (4, 5) . Thus, injury from intestinal IR may cause a local and systemic inflammatory response. As a result, morbidity and mortality associated with intestinal IR are high (ϳ70%) (2, 4) , and specific therapeutic interventions are needed.
It is well known that inflammatory tissue damage is accompanied by accumulation of extracellular adenosine, a naturally occurring antiinflammatory agent (6 -9) . Local tissue hypoxia or ischemia in inflamed areas represents one of the most important conditions leading to adenosine release and accumulation (9, 10) . At present, the exact source of adenosine during hypoxic or ischemic events is not well defined but likely results from a combination of amplified extracellular phosphohydrolysis of adenine nucleotides via surface ectonucleotidases (11, 12) and decreased adenosine uptake by the surrounding tissues (13) . During ischemia, extracellular nucleotides (ATP/ADP) liberated at inflammatory or hypoxic tissue sites from various cells, including PMNs (14) , platelets, mast cells, and endothelial cells (6, 7) , are metabolized to adenosine via surface expressed ecto-nucleotidases (CD39 and CD73). Ectoapyrase (CD39) converts ATP/ADP to AMP and ecto-5Ј-nucleotidase (CD73) subsequently converts AMP to adenosine (15) .
A few studies suggest that adenosine signaling may modulate tissue protection of the intestine during inflammation. Early studies showed that adenosine applied to the topical surface of the intestine inhibits intestinal IR-induced neutrophil infiltration, oxidative damage, and mucosal destruction in the intestine (16 -19) . CD39-deficient mice developed more profound intestinal IR injury and demonstrated increased mortality, and CD39 supplementation inhibited increased vascular permeability associated with IR injury (20) . These studies suggest that adenosine modulates intestinal IR injury. However, to date, there is no direct evidence implicating CD73, the "pacemaker" enzyme of extracellular adenosine production, in protection against intestinal IR-induced injury. Therefore, we performed pharmacologic and genetic studies to investigate the role of CD73 in murine intestinal IR injury.
MATERIALS AND METHODS

Mice
Mice deficient in CD73 (cd73 Ϫ/Ϫ ) on the C57BL/6 strain have been described previously (12) . Cd73 ϩ/ϩ littermates (WT) were matched in age, gender, and weight and used as controls.
Gastrointestinal ischemia-reperfusion injury
All animal protocols were in accordance with the German Law on the Protection of Animals for use of living animals and were approved by the Institutional Animal Care and Use Committee of the University Hospital and the Regierungsprä-sidium Tü bingen. All mice were placed on a temperaturecontrolled heating table with a rectal thermometer probe attached to a thermal feedback controller to maintain body temperature at 37°C. Cd73 Ϫ/Ϫ or WT mice were anesthetized with isoflurane (The Multi-Station Research Anesthesia System, Harvard Apparatus, March-Hugstetten, Germany). After a midline laparotomy, intestinal ischemia was produced by clamping the superior mesenteric artery for 15 min, followed by unclamping for 3 h of reperfusion as described previously (21) (22) (23) . Sham-operated controls underwent the same surgical procedure but without intestinal IR. In some experiments, WT or cd73 Ϫ/Ϫ mice were treated with a specific inhibitor of ecto-5Ј-nucleotidase, 5Ј-[␣␤-methylene] diphosphate (APCP; 40 mg/kg/h; Sigma, St. Louis, MO, USA), given via an intracarotid arterial catheter (24) prior to ischemia; the nonmetabolizable adenosine analog 5Ј-N-ethylcarboxamidoadenosine (NECA, Sigma-Aldrich; dosage of 0.1 mg/kg i.p. plus 0.1 mg/kg s.c.) (12) ; or dimethyloxallyl glycine (DMOG), a prolyl-4-hydroxylase inhibitor which up-regulates HIF activity (Frontier Scientific, Logan, UT, USA; dosage of 40 or 200 mg/kg i.p. 4 h prior to ischemia). For reconstitution experiments, cd73 Ϫ/Ϫ mice were reconstituted with a bolus of 2 U of soluble 5Ј-nucleotidase (5Ј-NT) purified from Crotalus atrox venom (given via an intracarotid arterial catheter; Sigma) (12, 24) , followed by 40 U/kg/h intra-arterial (i.a.) infusion during IR. In additional experiments, WT mice were treated with a bolus of 5Ј-NT (2 U, i.a.), followed by 20 U/kg/h, i.a. during IR. After 3 h of reperfusion, mice were euthanized, and intestinal and lung samples were immediately frozen in liquid nitrogen for further investigations. Blood was collected via cardiac puncture, transferred to a 2-ml tube, and centrifuged (10 min at 3000 rpm); serum was transferred to a new tube and frozen at -80°C. 
Real-time RT-PCR
To examine the influence of intestinal IR on CD73 transcript levels, C57BL/6 mice underwent intestinal ischemia followed by reperfusion. Mice were euthanized at indicated time points, and mucosal scrapings were performed. Total RNA was isolated using the total RNA isolation NucleoSpin RNA II Kit according to the manufacturer's instructions (Macherey & Nagel, Düren, Germany). cDNA synthesis was performed using reverse transcription according to the manufacturer's instructions (i-script Kit; Bio-Rad Laboratories, Munich, Germany). The primer sets for the PCR reaction contained 1 M sense and 1 M antisense with SYBR Green I (Molecular Probes, New Brunswick, NJ, USA). Primer sequences for murine CD73 were (sense/antisense, respectively) 5Ј-CAAATCCCACACAACCACTG-3Ј and 5Ј-TGCTCACT-TGGTCACAGGAC-3Ј. Murine ␤-actin sense primer, 5Ј-ACATTGGCATGGCTTTGTTT-3Ј and antisense primer, 5Ј-GTTTGCTCCAACCAACTGCT-3 were used to control for the starting template. Levels and fold change in mRNA were determined as described previously (27) .
Western blot analysis
The Western blot analysis technique was used to examine total CD73 protein level. Briefly, protein extracts were solubilized in reducing Laemmli sample buffer and heated to 70°C for 10 min. Samples were resolved on a 10% polyacrylamide gel and transferred to nitrocellulose membranes. The membranes were blocked at 4°C overnight in 5% nonfat dry milk (Applichem, Cheshire, CT, USA) in Tris-buffered saline with Tween (TBS-T). The membranes were incubated with 4 l/ml CD73 rabbit polyclonal antibody raised against the C terminus (Abgent, San Diego, CA, USA) for 2 h at room temperature, followed by 5-min washes in TBS-T. The membranes were then incubated with 1:2000 goat anti-rabbit horseradish peroxidase (HRP) (Santa Cruz Biotechnology, Danvers, MA, USA). The wash was repeated, and proteins were detected by enhanced chemiluminescence. To ensure equal loading, membranes were detected for ␤-actin. Blots were stripped for 15 min at room temperature in stripping buffer (Pierce, Rockford, IL, USA) and washed and blocked as mentioned above. Membranes were incubated with ␤-actin rabbit monoclonal antibody (dilution 1:1000) (Cell Signaling) for 2 h at room temperature followed by 5 min washes in TBS-T. The membranes were then incubated with 1:2000 goat anti-rabbit HRP (Santa Cruz Biotechnology). The wash was repeated, and proteins were detected by enhanced chemiluminescence.
Myeloperoxidase (MPO) activity
MPO activity, an index of neutrophil infiltration, was measured in intestinal and lung homogenates as described previously (21) (22) (23) 25) .
Alanine (ALT) and aspartate (AST) aminotransferase serum activity
Serum ALT and AST levels were measured using a microtiter plate adaptation of a commercially available kit (Teco Diagnostics, Anaheim, CA, USA) (26).
IL-1 and IL-6 serum activity
Serum cytokine activity was measured using a commercially available ELISA kit (R&D Systems, Minneapolis, MN, USA).
Histological sections
Mice were euthanized at the indicated time points and intestine was removed and fixed in Tissue-Tek (Sakura Finetek Europe, Zoeterwoude, The Netherlands). Cryostat sections (5 m) were mounted on glass slides, air dried, and postfixed in acetone/methanol (1:1) for 10 min at room temperature. Sections were stained with hematoxylin and eosin (H&E) and the extent of the mucosal damage was quantified, as described previously using this model (23) using a semiquantitative grading system adapted from Chiu et al. (28) . Injury was classified using the following 5-point scale, in which a numerical score was assigned based on the degree of mucosal and submucosal damage: 0 ϭ normal; 1 ϭ development of apical subepithelial space; 2-3 ϭ epithelial lifting; 4 ϭ cellular infiltration; and 5 ϭ disintegration of lamina propria, hemorrhage, and ulceration.
Adenosine measurements
Jejunum from mice was removed and immediately snapfrozen with clamps that were precooled to the temperature of liquid nitrogen within a time lag of 3 to 5 s. The frozen jejunum was pulverized under liquid nitrogen, and the tissue protein was precipitated with ice-cold 0.6 N perchloric acid. Tissue adenosine levels were determined as described previously (29) .
RESULTS
Intestinal CD73 is induced by IR
On the basis of previous studies showing tissue protection by extracellular adenosine generated via hypoxia-inducible CD73 (11, 12, 30) , we hypothesized that CD73-dependent adenosine generation may play an important role during intestinal IR. Therefore, we investigated intestinal CD73 expression using our previously described model of intestinal IR (21) (22) (23) . To define transcriptional effects of intestinal IR, intestinal epithelial scrapings were harvested at the indicated reperfusion time points following 15 min ischemia (Fig. 1A) and assessed via real-time RT-PCR. A strong induction of CD73 mRNA was observed immediately following ischemia (12.1Ϯ1.6-fold, PϽ0.001) with a steady decrease over the reperfusion time period (Fig. 1B) . As the next step, we measured CD73 by Western blot analysis from intestinal epithelial scrapings and confirmed increases in CD73 protein after intestinal IR compared with sham controls (Fig. 1C) . Taken together, these data support transcriptional and translational induction of CD73 during intestinal IR.
In addition to hypoxia (11, 12, 30) and hypoxiainducible factor-1 (HIF-1) (31), inflammatory cytokines may regulate CD73. For example, interferon-␣ was shown to up-regulate CD73 expression on endothelial cells in vitro and in human patients in vivo and correlate positively with increased enzymatic activity and adenosine production (32) . To determine whether inflammatory cytokines regulate CD73 in intestinal epithelial cells, Caco or T84 cells were treated with either IL-1␤ or IL-6. After 24 h of treatment, CD73 transcript levels were measured via RT-PCR. Caco cells stimulated with IL-1␤ resulted in a significant increase in CD73 transcript levels, while T84 cells stimulated with IL-1␤ or IL-6 caused a mild increase in CD73 mRNA (Fig. 1D) . Collectively, these results suggest that inflammatory cytokines contribute to the induction of CD73 during intestinal ischemia reperfusion injury.
CD73 inhibition accentuated injury following intestinal IR
After having shown a robust induction of CD73 during intestinal IR injury, we next performed pharmacological studies to determine the functional role of CD73 in this model. WT mice were subjected to 15 min of superior mesenteric artery occlusion and 3 h of reperfusion following treatment with the specific CD73 inhibitor APCP (40 mg/kg/h, i.a.) or vehicle (saline). Consistent with previous studies (21) (22) (23) , IR was associated with a significant increase in intestinal MPO activity ( Fig. 2A; PϽ0.05) . However, neutrophil tissue infiltration was dramatically increased following APCP-inhibition of CD73 ( Fig. 2A; PϽ0.05) . Similarly, increases in pulmonary MPO activity were significantly enhanced in mice exposed to IR injury following CD73 inhibition ( Fig. 2B; PϽ0.05 ). As shown in Fig. 2C , APCP treatment prior to intestinal IR also resulted in a significant increase in secondary hepatic injury as measured by serum AST. Additionally, inhibition of CD73 caused a significant increase in serum IL-6 and IL-1␤ following IR (Fig. 2D, E, respectively). Histological analysis revealed that intestinal IR also significantly increased the intestinal injury score in APCP-treated mice compared to WT mice that were treated with vehicle (Fig. 2F, G) . Taken together, these studies provide pharmacological evidence of CD73-mediated tissue protection during intestinal IR. Transcriptional responses to intestinal IR were measured following isolation of RNA from intestinal epithelial scrapings from WT mice that were anesthetized (A) and after a midline laparotomy (L) were subjected to 15 min of ischemia, followed by the indicated reperfusion times. RNA was also isolated from control (C) mice that did not undergo IR. B) CD73 mRNA levels were determined by real-time RT-PCR. Data were calculated relative to an internal housekeeping gene (␤-actin) and expressed as fold change Ϯ se compared to sham (C) mice; 4 mice/group. C) Intestinal scrapings from WT sham mice or mice that were subjected to 15 min of ischemia followed by 90 or 180 min reperfusion were flash-frozen and lysed; proteins were resolved by SDS-PAGE and transferred to nitrocellulose, and membranes were probed with anti-CD73 antibody. A representative Western blot of two is shown. The same blot was reprobed for ␤-actin as a control for protein loading. D) Caco-2 and T84 human intestinal epithelial cells were stimulated with 10 ng/ml of human recombinant IL-1␤ or IL-6. After 24 h of treatment, CD73 transcript levels were measured via RT-PCR. Data were calculated relative to an internal housekeeping gene (␤-actin) and expressed as fold change Ϯ se compared to untreated control (C) cells; 3 samples/group.
Intestinal IR injury is increased in cd73
Ϫ/Ϫ mice On the basis of these pharmacological findings demonstrating that CD73 inhibition enhances IR-induced injury, we next investigated the role of CD73 in protection against intestinal IR in cd73 gene-targeted mice (12) . Following intestinal IR, cd73 Ϫ/Ϫ mice demonstrated significantly higher intestinal MPO levels in comparison to littermate control (WT) mice ( Fig. 3A;  PϽ0.01) . Similarly, pulmonary MPO levels were in- Figure 2 . Inhibition of CD73 by APCP increases injury. Injury was measured after WT mice were treated with APCP (40 mg/kg/h, i.a.) or sterile saline and subjected to 15 min of ischemia, followed by 3 h reperfusion. Injury was measured for the following parameters: Intestinal MPO (A), lung MPO (B), AST (C), IL-6 (D), IL-1 (E), H&E staining of jejunum sections (ϫ200) (F), and quantification of ischemic injury (medianϮrange; nϭ3-5 mice/group) (G). All other results are expressed as mean Ϯ se; 8 -12 mice/group. creased in cd73 Ϫ/Ϫ mice ( Fig. 3B; PϽ0.05) . Biochemical analysis revealed that intestinal IR significantly increased serum AST (Fig. 3C) and ALT (Fig. 3D ) concentrations in cd73 Ϫ/Ϫ mice compared to littermate controls. Cd73
Ϫ/Ϫ mice also demonstrated significantly higher IL-6 (Fig. 3E ) and IL-1␤ (Fig. 3F) cytokine concentrations in the serum than WT control mice following intestinal IR. Taken together, these data reveal, for the first time, genetic evidence for CD73-dependent protection against intestinal IR. 
Histological signs of intestinal injury by intestinal IR are increased in cd73
Ϫ/Ϫ mice To confirm enhanced injury observed in cd73 Ϫ/Ϫ mice, we examined jejunum from WT littermate controls or cd73 Ϫ/Ϫ mice. Intestinal IR resulted in loss and shortening of intestinal villi and marked intestinal epithelial cell denudation (Fig. 4A) . However, the observed injury was significantly increased in cd73 Ϫ/Ϫ mice compared to WT controls after intestinal IR, as semiquantitative histological analysis of these sections demonstrated an increase in the Chiu index (28), from 2 in WT mice to 3.5 in cd73 Ϫ/Ϫ mice ( Fig. 4A, B; PϽ0.01) . Taken together, these data provide strong evidence for a role of CD73 in attenuating intestinal IR injury.
Intestinal adenosine concentrations are decreased in cd73
Ϫ/Ϫ mice Next, we performed studies to confirm CD73-mediated phosphohydrolysis of AMP in intestinal IR injury by measuring adenosine tissue concentrations. To do this, we measured jejunal adenosine levels in tissues shock frozen immediately following 15 min of intestinal ischemia or in sham-operated controls. Intestinal adenosine concentrations were significantly increased following in WT IR mice compared to sham controls ( Fig. 5; PϽ0.001). In contrast, baseline intestinal adenosine levels of cd73 Ϫ/Ϫ were significantly lower than littermate controls ( Fig. 5; 2.71Ϯ0.2-fold, PϽ0 .01) and did not increase with intestinal ischemia (Fig. 5) . Taken together, these data demonstrate that increases in intestinal adenosine during ischemia require CD73 activity.
Adenosine receptor stimulation decreased intestinal IR injury
To confirm that adenosine regulates intestinal IR injury, WT or cd73 Ϫ/Ϫ mice were treated with NECA, a nonspecific adenosine receptor agonist. Stimulation of adenosine receptors resulted in a significant inhibition of neutrophil infiltration into the intestinal and lung tissues (Fig. 6A, B, respectively) , as well as a significant decrease in serum ALT (Fig. 6C ) and proinflammatory cytokine levels (Fig. 6D, E) in cd73 Ϫ/Ϫ mice. In fact, treatment of cd73 Ϫ/Ϫ mice with NECA resulted in a WT phenotype, suggesting that adenosine regulates intestinal IR injury via binding to adenosine receptors.
Reconstitution of cd73
Ϫ/Ϫ mice with soluble 5-nucleotidase resulted in a WT phenotype As proof of principle and to demonstrate that an increase in functional injury parameters in cd73 Ϫ/Ϫ mice reflects lack of ecto-5Ј-nucleotidase enzyme activity, we next reconstituted cd73 Ϫ/Ϫ mice with soluble 5Ј-nucleotidase (5Ј-NT) from Crotalus atrox venom (12) and subjected them to intestinal IR. As shown in Fig. 7 , reconstitution of cd73 Ϫ/Ϫ mice with soluble 5Ј-nucleotidase attenuated injury, as demonstrated by a significant decrease in intestinal MPO (Fig. 7A) , ALT (Fig. 7B) , and proinflammatory cytokines IL-6 (Fig. 7C) and IL-1␤ (Fig. 7D) . Histological analysis confirmed that 5Ј-NT treatment was associated with reconstitution of a WT phenotype (Fig. 7E, F) . Taken together, these results confirm our genetic studies, demonstrating that CD73 plays a crucial role in protection against intestinal IR-induced injury. 
Treatment of intestinal ischemia with soluble 5-nucleotidase in WT mice decreased IR injury
We next pursued the usefulness of 5Ј-NT treatment of intestinal ischemia in WT mice. For this purpose, we treated WT mice with 5Ј-nucleotidase prior to intestinal IR (12) . As shown in Fig. 8A-C , injury following intestinal IR was inhibited by treatment of WT mice with soluble 5Ј-nucleotidase. Intestinal histological analysis confirmed this protection (Fig. 8D, E) . Taken together, these data demonstrate a therapeutic effect of treatment with soluble 5Ј-nucleotidase in intestinal IR.
Mechanism of CD73 regulation
One way that oxygen homeostasis is coordinated is through the transcriptional regulator HIF-1 (33). Recently, much attention has focused on HIF-1 as a key regulator of a wide variety of oxygen-regulated genes, including CD73 (31) . To determine whether the observed protective effects of CD73-dependent adenosine production during intestinal IR are regulated by HIF-1, WT or cd73 Ϫ/Ϫ mice were treated i.p. with 40 or 200 mg/kg of dimethyloxaloylglycine (DMOG), a nonspecific prolyl hydroxylase inhibitor, which activates HIF-1 activity by inhibiting proteasomal degradation of the HIF-1␣ subunit. As shown in Fig. 9 , WT mice treated with DMOG showed a significant decrease in AST (Fig.  9A) , ALT (Fig. 9B ) and IL-6 (Fig. 9C) following intestinal IR. In contrast, DMOG had no effect on cd73 Ϫ/Ϫ mice ( Fig. 9A-C) . These data suggest that HIF-1 regulates CD73 during intestinal IR and thus activation of HIF-1 inhibits intestinal IR injury.
DISCUSSION
In the present study, we pursued the contribution of extracellular adenosine production in protection against intestinal IR-induced injury. Transcriptional and translational profiling of intestinal tissue revealed a prominent induction of epithelial cell CD73. Pharmacological inhibition or targeted gene deletion of CD73 significantly increased injury following intestinal IR demonstrating the importance of this enzyme in acute ischemia. Moreover, soluble 5Ј-nucleotidase treatment was associated with lower levels of injury. Taken together, these studies suggest that manipulation of CD73 enzymatic activity to increase extracellular adenosine production represents a therapeutic strategy for the treatment of acute ischemic injury of the intestine and that deficiency of CD73 may result in enhanced injury during intestinal ischemic events.
Our results showing transcriptional and translational induction of intestinal epithelial cell CD73 are consistent with previous studies that found that exposure of intestinal epithelial cells to ambient hypoxia (2% oxygen) resulted in a robust induction of CD73 transcript, protein, and function (11, 31) . Similarly, studies in cd73 Ϫ/Ϫ mice demonstrated increased vascular leakage syndrome and pulmonary edema on hypoxia exposure (8% oxygen over 4 h) (12) , confirming a role of CD73-dependent adenosine production in multipleorgan injury during hypoxic events. Studies examining the CD73 gene promoter found a binding site for hypoxia-inducible factor (HIF)-1␣ and inhibition of HIF-1␣ expression resulted in attenuation of hypoxiainducible CD73 expression (31), demonstrating a HIF-1␣-dependent pathway for CD73 induction by hypoxia. In addition to hypoxia, HIF-1␣ protein levels were induced in the intestinal mucosa and persisted after 1 and 3 h of reperfusion in a rat model of intestinal IR injury (34) . Furthermore, in the present study, we show that cd73 Ϫ/Ϫ mice were resistant to the effects of the HIF-1 activator, DMOG, while WT mice treated with DMOG demonstrated a dose-dependent decrease in intestinal IR injury markers. Therefore, it is likely that the observed protective effects of CD73-dependent adenosine production during intestinal IR are transcriptionally coordinated by HIF and that activation of HIF-1 may provide an additional potential therapeutic approach to decrease intestinal IR injury.
In the present study, we show that pharmacological inhibition or genetic deletion of CD73 due to decreased adenosine generation significantly increased infiltration of neutrophils into the intestinal tissue following intestinal IR. Human intestinal epithelial cells express surface CD73 abundantly on their apical domain and to a lesser extent on the basolateral domain (35) . In vitro results show that neutrophils migrate across intestinal mucosa (36, 37) and release 5Ј-ATP, which is rapidly converted to 5Ј-AMP (14, 38) . 5Ј-AMP is subsequently degraded into adenosine at the apical pole by CD73 anchored within the intestinal epithelial luminal membrane (38, 39) , where it functions as a paracrine and/or autocrine mediator of chloride secretion in intestinal epithelial cells (38) . The ability of intestinal epithelial cells to respond to 5Ј-AMP with chloride secretion and hence, water secretion, is an important component of the epithelial barrier that protects the intestine by preventing translocation of bacteria, bacterial products, and antigens to lamina propria (40, 41) . A previous study showed that CD73 inhibition using APCP resulted in a significant increase in hypoxia-induced intestinal permeability (31), suggesting that hypoxia-induced CD73 in vivo may provide a protective mechanism for the intestinal barrier during episodes of decreased oxygen delivery. Furthermore, it has been shown that adenosine binds to surface-expressed adenosine receptors on neutrophils to limit excessive accumulation of neutrophils within tissues, and as such, functions as a feedback loop to attenuate potential tissue injury (30) . CD39 and CD73 Ϫ/Ϫ mice with soluble 5Ј-nucleotidase decreases injury in cd73 Ϫ/Ϫ mice. Injury was measured after cd73 Ϫ/Ϫ mice were reconstituted with 5Ј-nucleotidase (2 U bolus prior to ischemia, followed by 40 U/kg/h, i.a.) or sterile saline and subjected to 15 min of ischemia, followed by 3 h reperfusion. Injury was measured for the following parameters: Intestinal MPO (A), ALT (B), IL-6 (C), IL-1 (D), H&E staining of jejunum sections (ϫ200) (E), and quantification of ischemic injury (F) (medianϮrange; nϭ3-5 mice/group). All other results are expressed as mean Ϯ se; 8 -12 mice/group.
were identified as critical control points to attenuate excessive neutrophil accumulation during hypoxia (30) . Thus, one mechanism for adenosine protection in the intestine may be neutrophil-intestinal epithelial crosstalk.
Our results also demonstrate that a nonselective adenosine receptor agonist inhibited intestinal IR injury, suggesting that CD73-dependent adenosine production modulates intestinal IR injury via adenosine receptor stimulation. In terms of specific aden- Figure 8 . Treatment with soluble 5Ј-nucleotidase decreases injury in WT mice. Injury was measured after WT mice were treated with 5Ј-nucleotidase (2 U bolus prior to ischemia, followed by 20 U/kg/h, i.a.) or sterile saline and subjected to 15 min of ischemia, followed by 3 h of reperfusion. Injury was measured for the following parameters: Intestinal MPO (A), ALT (B), IL-1 (C), H&E staining of jejunum sections (ϫ200) (D), and quantification of ischemic injury (medianϮrange; nϭ3-5 mice/group) (E). All other results are expressed as mean Ϯ se; 8 -12 mice/group. osine receptors, previous studies on the contribution of adenosine receptor signaling in the intestine have revealed conflicting results. Treatment with an A1 receptor agonist was shown to protect against intestinal IR injury in the rat (42) . However, other studies demonstrate that the A 2B AR mediates enhancement of chloride secretion induced by adenosine (43, 44) . Additionally, we previously demonstrated that A 2B AR is selectively up-regulated by hypoxia and that A 2B AR antagonists effectively neutralize ATP-mediated changes in posthypoxic endothelial permeability (11) . A 2B AR is also involved in resealing of endothelia during transendothelial migration of neutrophils (45) , particularly during conditions of limited oxygen availability (11) . Furthermore, the A 2B AR is expressed in intact human intestinal epithelia (43) and appears to be the only adenosine receptor present in T84 cells in both apical and basolateral membranes (43, 46) . However, the importance of the A 2A AR was shown to play a critical role in regulation of colitis (47) . Further studies using a combined pharmacological and genetic approach using adenosine receptor-deficient mice will be required to identify adenosine signaling mechanisms involved in modulation of IR injury to the small intestine.
In the present study, we demonstrate that CD73 plays an antiinflammatory role during gastrointestinal ischemia/reperfusion injury. Reconstitution studies with adenosine analogs or with soluble 5Ј-nucleotidase suggest that the tissue-protective effects of CD73 in this model are related to its enzymatic function and role in elevating extracellular adenosine levels. In contrast, some previous studies suggest that CD73 may function in mediating lymphocyte adhesion to the endotheliumindependent of its enzymatic function. As such, it has been suggested that engagement of CD73 on the lymphocyte surface increases integrin-mediated binding of lymphocytes to endothelium, providing a possible mechanism for regulating lymphocyte-endothelial cell contacts in high endothelial venules (48 -50) . In contrast to these findings, more recent studies of gene-targeted mice for cd73 show an anti-inflammatory and tissue-protective role of CD73, which is related to its functional role in elevating extracellular adenosine levels (12, 24, 51, 52) .
In summary, the present study demonstrates that CD73-mediated phosphohydrolysis of AMP is a critical control point for endogenous adenosine generation and modulation of injury during intestinal IR. Genetic deficiency of CD73 may result in excessive injury during acute gastrointestinal ischemia. The significant attenuation of intestinal injury following ischemia by soluble 5Ј-nucleotidase treatment also suggests possible new strategies to ameliorate the consequences of intestinal ischemia. 
